← Browse by Condition
Medical Condition
primary peritoneal carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2, Phase 2
NCT07480954 Phase 1, Phase 2
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)
Enrollment
36 pts
Location
China
Sponsor
Beijing Biotech
NCT05200260 Phase 2
Recruiting
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
Enrollment
220 pts
Location
China
Sponsor
Shanghai Gynecologic Oncology ...